Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Abbott Laboratories (NYSE:ABT) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 22, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is $1.34 EPS, expectations were $1.34. Operator: Good morning and thank you for standing by.
What’s Driving Abbott Laboratories (ABT) Stock’s 9.45% Surge Over the Past Month?
Oppenheimer has recently initiated Abbott Laboratories (ABT) stock to Outperform rating, as announced on October 8, 2024, according to Finviz. Earlier, on September 19, 2024, Piper Sandler had initiated the stock to Overweight,
Mizuho Securities Reaffirms Their Hold Rating on Abbott Laboratories (ABT)
Mizuho Securities analyst Anthony Petrone maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday. The company’s
Is Abbott Laboratories (ABT) Expected to Post Impressive Earnings This Week?
We recently published a list of 10 Stocks Expected To Post Impressive Earnings This Week. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks expected to post impressive earnings this week.
Why Is Abbott Laboratories (ABT) Stock Surpassing 6.96% from Its 50-Day SMA?
Oppenheimer has recently initiated Abbott Laboratories (ABT) stock to Outperform rating, as announced on October 8, 2024, according to Finviz. Earlier, on September 19, 2024, Piper Sandler had initiated the stock to Overweight,
RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT)
In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Abbott Laboratories (ABT – Research Report),
Abbott Laboratories: Now Back In The Buy Zone (Rating Upgrade)
Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month.
1d
Market Whales and Their Recent Bets on ABT Options
With a trading volume of 5,249,687, the price of ABT is down by -0.19%, reaching $122.98. Current RSI values indicate that ...
stocknews
1d
3 Healthcare IT Stocks Driving Digital Transformation
The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...
coinspeaker
2d
Arcblock (ABT) Trading Volume Surges 2000% After Trump AI Endorsement
Arcblock (ABT) shot up by more than 45% in the past 24 hours and claimed a daily high of $1.92, facing resistance at $2.
MassDevice
3d
Abbott sales come up just shy of Q4 expectations on Wall Street, highlights EP growth
Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright ...
2d
Abbott Laboratories: Strong Performance and Promising Outlook Support Buy Rating
Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to ...
3d
Abbott Q4 Earnings Meet, Margins Down, Stock Falls in Pre-Market
Abbott Laboratories ABT reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.34, in line with the Zacks ...
3d
on MSN
Trump expands on Texas Gov. Greg Abbott’s border policies
Only minutes after being sworn in as the 47th President of the United States, President Donald Trump praised Texas Gov. Greg ...
2d
on MSN
Gov. Abbott calls on Congress to pay back Texas for $11.1B spent on border
Gov. Abbott sent letters on Thursday to U.S. Congressional leaders requesting the federal government reimburse Texas $11.1 billion for border budget.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Abbott Laboratories
New York Stock Exchange
Earnings per share
Feedback